Integrating New Data From AIDS 2022

Join 2 leading experts for an interactive meeting focused on the most clinically relevant data presented at AIDS 2022, as well as other key studies that may be significant to the advancement of HIV patient care. Case vignettes will be used to explore integration of findings into everyday patient management.

Agenda

The timing and agenda for each webinar is as follows:

  • Introduction and Program Overview
  • Key Findings From AIDS 2022
    • Clinical studies of established antiretroviral agents
    • The clinical role(s) of new and investigational ART regimens
    • HIV prevention strategies
  • Question and Answer Session

Events

Date / Time
Event Details
9/13/2022
6:00 PM

Integrating New Data From AIDS 2022

Miami Beach, FL
Smith and Wollensky - Miami Beach Details
9/15/2022
6:00 PM

Integrating New Data From AIDS 2022

San Francisco, California
Morton’s The Steakhouse - San Francisco Details
9/20/2022
6:00 PM

Integrating New Data From AIDS 2022

New York, NY
Smith & Wollensky - New York Details

Faculty

Program Director
Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN

Professor
Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Faculty
Jonathan Appelbaum, MD, FACP, AAHIVS

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Chair,
Department of Clinical Sciences
Florida State University College of Medicine
Tallahassee, Florida

Faculty
Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Faculty
Timothy J. Wilkin, MD, MPH

Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate best practices in the evidence-based management of ART across the spectrum of ART experience
  • Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection
  • Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-174-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.